Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma
about
Gemcitabine-based chemotherapy for advanced biliary tract carcinomasDuodenal adenocarcinoma: Advances in diagnosis and surgical managementManagement of ampullary neoplasms: A tailored approach between endoscopy and surgeryAmpullary adenocarcinoma - differentiation matters.Clinicopathological Study of Carcinoma of the Ampulla of Vater with Special Reference to MUC1, MUC2 and MUC5AC ExpressionThe clinical importance of tumour-infiltrating macrophages and dendritic cells in periampullary adenocarcinoma differs by morphological subtype.The Association between Survival and the Pathologic Features of Periampullary Tumors Varies over Time.Generation and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell linesCOX-2 overexpression in resected pancreatic head adenocarcinomas correlates with favourable prognosis.Reduced expression of the polymeric immunoglobulin receptor in pancreatic and periampullary adenocarcinoma signifies tumour progression and poor prognosisIntestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal originPrognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma.Prognostic impact of immunohistochemical expression of CK7 and CK20 in curatively resected ampulla of Vater cancer.Tumors of ampulla of Vater: A case series and review of chemotherapy optionsThe role of lymph nodes in predicting the prognosis of ampullary carcinoma after curative resection.Characterization of various cell lines from different ampullary cancer subtypes and cancer associated fibroblast-mediated responses.Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1, 2 and 3 in Periampullary Adenocarcinoma.Adenocarcinoma of the ampulla of Vater: predictors of survival and recurrence after curative radical resectionKRAS mutation as a prognostic factor in ampullary adenocarcinoma: a meta-analysis and review.Immunohistochemical Typing of Adenocarcinomas of the Pancreatobiliary System Improves Diagnosis and Prognostic StratificationThe expression of PTEN is associated with improved prognosis in patients with ampullary adenocarcinoma after pancreaticoduodenectomy.Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma.Regulatory T cells that co-express RORγt and FOXP3 are pro-inflammatory and immunosuppressive and expand in human pancreatic cancer.Gene expression profiling of ampullary carcinomas classifies ampullary carcinomas into biliary-like and intestinal-like subtypes that are prognostic of outcome.Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours.Bone and brain metastases from ampullary adenocarcinomaA retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapy.2564 resected periampullary adenocarcinomas at a single institution: trends over three decades.Clinical, morphologic, and immunophenotypic characteristics of ampullary carcinomas with an emphasis on SMAD4 expression.Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.Differential expression of E-cadherin, β-catenin, and S100A4 in intestinal type and nonintestinal type ampulla of Vater cancers.Prognostic factors for long-term survival in patients with ampullary carcinoma: the results of a 15-year observation period after pancreaticoduodenectomy.Use of a standardized diagnostic approach improves the prognostic information of histopathologic factors in pancreatic and periampullary adenocarcinoma.Targeted therapy for biliary tract cancers.Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part I: diagnosis-clinical staging and pathology.Resection margin involvement and tumour origin in pancreatic head cancer.Ampullary cancer--a separate clinical entity?Cytological features of mixed adenoneuroendocrine carcinoma of the ampulla: two case reports with review of literature.Poorly cohesive adenocarcinoma of the ampulla of Vater: a case report.MDCT and MRI of the ampulla of Vater. Part I: technique optimization, normal anatomy, and epithelial neoplasms.
P2860
Q24187573-C350C14C-C4C6-430E-A220-280E407C5BA3Q26750192-BEBFC8B8-771E-43E8-B5CC-9B97A331B77AQ26799743-95CA6B79-B8CE-43C2-8BAB-664D3BE669F8Q33365424-08448838-286E-4B33-8E39-286E81C1B445Q33831908-226DC5CD-6BB1-46C4-BB4E-70597E513008Q33869036-65FC3857-53B8-42A3-90F9-4199ACB6A2C0Q33914755-4D45D2B8-1A89-42D9-B4D3-E3E952B1A0D6Q34078502-207AA2DD-FADE-496E-9A1C-C1861CC31813Q34502422-83A7E5A7-70D1-4BFC-A9A1-88D71AAA24D1Q34514322-06BBC922-D419-4D3C-AA56-0ED519A7E452Q34992861-BCFB544B-77F3-496F-9595-FBFEDB1BF237Q35647464-C30AD934-3627-4E0D-A51B-D4FD3610F783Q35851586-515A1343-F4E1-4BB8-973A-3648B97F46BBQ35854505-24E85A44-B230-4C16-BF2A-2525A744AC4EQ35885352-C928C091-AF72-4472-BB92-4F1A3A3D793FQ35948210-25E5DBF6-AF68-4C9A-AAA5-4DB5295C1E28Q35987242-7F94672B-7C4D-4BF3-BAB8-9E8DD60A54DDQ36091760-AE887AAE-ABAC-4A3A-A8AC-AEA4F7159371Q36102524-5E28613C-1F69-4646-B67D-A87917BB0212Q36187546-85A108C4-F2A4-411D-AB49-4A92D63986FAQ36268915-4CDEDB2A-1943-4208-8173-32E21BCACC65Q36286689-E19E239B-9464-4F03-A89E-49D18BC25E4AQ36821258-AB7B9AEF-2A5E-4112-89BD-CAA41CEBEE39Q36919864-98335DB8-17E3-4D4B-B0C8-0DA2C3397FC9Q37187307-64C9653D-D78E-422A-BDDD-4543C88B016CQ37214618-7565B902-6A7A-41CC-A0F1-E3D1D1423E2EQ37345196-0120913E-FC90-4A38-B6CF-B7CDD8C5D7D9Q37480871-223B836A-9DAD-4E91-8997-65BAA20C38EFQ37525363-C375DC15-1EE2-4A23-AB62-F2BDB73544F6Q37538915-78141388-96EE-4351-B790-0B04F1385375Q37564069-38A42FB6-E502-4848-BB5C-23FC5A79F01EQ37645489-929C699C-B45C-49E4-9892-1B06607AC858Q37722822-2257D656-9D7D-42D4-9A11-E214884E6FF0Q37982650-CC2EE539-0A9D-4F2B-B78D-055A4ED429FCQ38001365-5DBAD04B-F6A1-45B7-B79B-3F61FCE0E11FQ38003878-735A18B5-382D-4A7A-8431-59E5AD3EA21AQ38181195-5699CDA5-E353-4231-8A7C-7105B99EC629Q38189766-4E57E640-3A68-4B25-AE8E-F2FEC941D6DAQ38459008-A5ECCA22-BC95-47CD-A014-20952CA21D2CQ38573652-43166250-BD4C-4C47-84A4-E4C83F912E18
P2860
Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Pancreatobiliary versus intest ...... d periampullary adenocarcinoma
@ast
Pancreatobiliary versus intest ...... d periampullary adenocarcinoma
@en
type
label
Pancreatobiliary versus intest ...... d periampullary adenocarcinoma
@ast
Pancreatobiliary versus intest ...... d periampullary adenocarcinoma
@en
prefLabel
Pancreatobiliary versus intest ...... d periampullary adenocarcinoma
@ast
Pancreatobiliary versus intest ...... d periampullary adenocarcinoma
@en
P2093
P2860
P356
P1433
P1476
Pancreatobiliary versus intest ...... d periampullary adenocarcinoma
@en
P2093
Arne Westgaard
Inger N Farstad
Milada Cvancarova
Ole Petter F Clausen
Oystein Mathisen
Svetlana Tafjord
Tor J Eide
P2860
P2888
P356
10.1186/1471-2407-8-170
P407
P577
2008-06-11T00:00:00Z
P5875
P6179
1029814476